Über das Unternehmen
- Firmenname (rechtlich): RODI FERTILITY
- Registrierungsland: Cyprus
- Adresse: Lapithou 14, office 206A, Engomi-Nicosia,, Nicosia
- Anzahl der Mitarbeiter: 1 - 24
Beschreibung:
RODI Fertility leads global innovation with patented immunomodulatory technology that regulates Natural Killer (NK) cells, a breakthrough in preventing miscarriage and supporting conception, offering first-in-class NK cell regulation for successful pregnancy. Its flagship product, RODI NK plus, has helped thousands of women achieve successful pregnancies through scientifically proven NK cell balance, with a portfolio also including RODI NK, RODI OVA and RODI VITA.
Geschäftsaktivitäten
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
Unternehmen in der Frühphase (Start-up)
Absatzmärkte
- Western Asia: , , ,
- Northern Europe: , , , , , ,
- Southern Europe: , , , , , ,
Unsere Produkte & Dienstleistungen
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
GMP
ISO
Proofs
CPHI Americas 2026
06/2026 – 06/2026
CPHI Americas 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen